Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Sildenafil in Neonates With PPHN
NCT01360671Phase 2Withdrawn
- Sponsor
- Viatris
- Start
- Mar 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sildenafil in persistent pulmonary hypertension of the newborn (PPHN), sponsored by Viatris. Planned start Mar 2012; status: withdrawn.
02
Drugs
sildenafil
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on NCT01360671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01360671.